The estimated Net Worth of International Ltd Fosun is at least $147 Milion dollars as of 8 November 2021. International Fosun owns over 4,000,000 units of Amneal Pharmaceuticals Inc stock worth over $92,864,736 and over the last 7 years International sold AMRX stock worth over $53,751,000.
International has made over 6 trades of the Amneal Pharmaceuticals Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently International sold 4,000,000 units of AMRX stock worth $28,080,000 on 8 November 2021.
The largest trade International's ever made was buying 7,348,242 units of Amneal Pharmaceuticals Inc stock on 6 December 2019 worth over $22,999,997. On average, International trades about 2,902,892 units every 181 days since 2018. As of 8 November 2021 International still owns at least 11,108,222 units of Amneal Pharmaceuticals Inc stock.
You can see the complete history of International Fosun stock trades at the bottom of the page.
International's mailing address filed with the SEC is ROOM 808, ICBC TOWER, 3 GARDEN ROAD, CENTRAL, HONG KONG, K3, 00000.
Over the last 6 years, insiders at Amneal Pharmaceuticals Inc have traded over $867,197,480 worth of Amneal Pharmaceuticals Inc stock and bought 3,818,425 units worth $12,997,905 . The most active insiders traders include Gp A, Llcbonderman Davidcou..., Holdings, Llc Aphc oraz International Ltd Fosun. On average, Amneal Pharmaceuticals Inc executives and independent directors trade stock every 18 days with the average trade being worth of $3,857,739. The most recent stock trade was executed by Andrew S Boyer on 14 August 2024, trading 62,711 units of AMRX stock currently worth $491,654.
an american pharmaceutical company, amneal develops and produces affordable medicines. the company was built upon a family tradition of quality and integrity. everything amneal does, across the full spectrum of its business, is in service to these guiding principles. amneal is committed to constantly elevating and refining the value it delivers to its customers and patients around the globe.
Amneal Pharmaceuticals Inc executives and other stock owners filed with the SEC include: